Breaking News Instant updates and real-time market news.

TXG

10x Genomics

$42.89 /

-3.475 (-7.49%)

04:37
08/18/22
08/18
04:37
08/18/22
04:37

10x Genomics downgraded to Sell from Neutral at Goldman Sachs

Goldman Sachs analyst Matthew Sykes downgraded 10x Genomics to Sell from Neutral with a price target of $35, down from $55, which represents 18% downside from current levels. The analyst expects a "materially slower cadence" to the company's sales growth rate in 2023 and 2024 versus consensus as it transitions to a multi-market, multi-product company. The growth rate for 10x's single cell analysis business is below what analysts have modeled over the next few years as its penetration into the academic market "has hit a ceiling amongst the high utilization, core lab customers," Sykes tells investors in a research note. He adds that the company's spatial and in situ offerings "are not yet of the size to help offset the deceleration in their core business."

OTHER BREAKING NEWS FROM THE FLY

Downgrade
United Utilities downgraded to Neutral from Overweight at JPMorgan » 06:13
12/06/22
12/06
06:13
12/06/22
06:13
UUGRY

United Utilities

$25.61 /

-0.11 (-0.43%)

JPMorgan analyst Pavan…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
UUGRY United Utilities
$25.61 /

-0.11 (-0.43%)

12/02/22 Morgan Stanley
United Utilities price target raised to 1,010 GBp from 990 GBp at Morgan Stanley
11/30/22 Credit Suisse
United Utilities price target raised to 990 GBp from 980 GBp at Credit Suisse
11/04/22 Morgan Stanley
United Utilities upgraded to Equal Weight from Underweight at Morgan Stanley
10/17/22 Credit Suisse
United Utilities price target lowered to 980 GBp at Credit Suisse
Hot Stocks
Fresenius Medical Care CEO Carla Kriwet departs amid 'strategic differences' » 06:13
12/06/22
12/06
06:13
12/06/22
06:13
FMS

Fresenius Medical

$16.22 /

-0.165 (-1.01%)

In a Monday press…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
FMS Fresenius Medical
$16.22 /

-0.165 (-1.01%)

FMS Fresenius Medical
$16.22 /

-0.165 (-1.01%)

11/09/22 Credit Suisse
Fresenius Medical price target lowered to EUR 32 from EUR 37 at Credit Suisse
11/03/22 Deutsche Bank
Fresenius Medical price target lowered to EUR 22 from EUR 24 at Deutsche Bank
11/02/22 UBS
Fresenius Medical price target lowered to EUR 27 from EUR 38 at UBS
11/02/22 Morgan Stanley
Fresenius Medical price target lowered to EUR 33 from EUR 34 at Morgan Stanley
Hot Stocks
BioVie's Alzheimer's candidate shows potential impact in Phase 2 trial » 06:13
12/06/22
12/06
06:13
12/06/22
06:13
BIVI

BioVie

$5.18 /

-0.275 (-5.04%)

BioVie announced data…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
BIVI BioVie
$5.18 /

-0.275 (-5.04%)

BIVI BioVie
$5.18 /

-0.275 (-5.04%)

07/22/22 Cantor Fitzgerald
BioVie initiated with an Overweight at Cantor Fitzgerald
03/14/22 Oppenheimer
BioVie initiated with an Outperform at Oppenheimer
01/24/22 B. Riley
BioVie price target lowered to $18 from $27 at B. Riley
BIVI BioVie
$5.18 /

-0.275 (-5.04%)

Hot Stocks
Acutus Medical receives CE Mark for AcQMap 3D Imaging and Mapping Catheter » 06:13
12/06/22
12/06
06:13
12/06/22
06:13
AFIB

Acutus Medical

/

+

Acutus Medical announced…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
AFIB Acutus Medical
/

+

AFIB Acutus Medical
/

+

06/24/22 BTIG
Acutus Medical price target lowered to $1.50 from $2.00 at BTIG
04/27/22 BTIG
Acutus Medical upgraded to Buy from Neutral at BTIG
02/24/22 JPMorgan
JPMorgan lays out potential takeover targets in medical technology
01/20/22 BTIG
BTIG cuts Acutus Medical to Neutral, says steeper expense reductions needed
AFIB Acutus Medical
/

+

Hot Stocks
Energous gets approval for 1W WattUp PowerBridge technology in South Korea » 06:13
12/06/22
12/06
06:13
12/06/22
06:13
WATT

Energous

$1.00 /

-0.025 (-2.44%)

Energous announced that…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
WATT Energous
$1.00 /

-0.025 (-2.44%)

WATT Energous
$1.00 /

-0.025 (-2.44%)

08/11/22 Ladenburg
Energous price target raised to $1.90 from $1.50 at Ladenburg
03/01/22 Ladenburg
Energous price target lowered to $1.50 from $5 at Ladenburg
WATT Energous
$1.00 /

-0.025 (-2.44%)

WATT Energous
$1.00 /

-0.025 (-2.44%)

Downgrade
Societe Generale downgraded to Neutral from Overweight at JPMorgan » 06:12
12/06/22
12/06
06:12
12/06/22
06:12
SCGLY

Societe Generale

$4.75 /

-0.12 (-2.46%)

JPMorgan analyst Delphine…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
SCGLY Societe Generale
$4.75 /

-0.12 (-2.46%)

SCGLY Societe Generale
$4.75 /

-0.12 (-2.46%)

11/18/22 Morgan Stanley
Societe Generale downgraded to Equal Weight from Overweight at Morgan Stanley
11/07/22 JPMorgan
Societe Generale price target lowered to EUR 33 from EUR 34 at JPMorgan
11/07/22 Deutsche Bank
Societe Generale price target raised to EUR 37 from EUR 34 at Deutsche Bank
11/02/22 Barclays
Societe Generale price target lowered to EUR 40 from EUR 42.30 at Barclays
SCGLY Societe Generale
$4.75 /

-0.12 (-2.46%)

SCGLY Societe Generale
$4.75 /

-0.12 (-2.46%)

Upgrade
Reinsurance Group upgraded to Outperform at RBC Capital amid strong demand » 06:12
12/06/22
12/06
06:12
12/06/22
06:12
RGA

Reinsurance Group

/

+

RBC Capital analyst Mark…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
RGA Reinsurance Group
/

+

RGA Reinsurance Group
/

+

05:17 Today RBC Capital
Reinsurance Group upgraded to Outperform from Sector Perform at RBC Capital
11/16/22 Citi
Reinsurance Group price target raised to $116 from $112 at Citi
11/07/22 RBC Capital
Reinsurance Group price target raised to $145 from $132 at RBC Capital
10/31/22 JPMorgan
Reinsurance Group downgraded to Neutral from Overweight at JPMorgan
RGA Reinsurance Group
/

+

Upgrade
General Electric upgraded to Outperform from Perform at Oppenheimer » 06:12
12/06/22
12/06
06:12
12/06/22
06:12
GE

General Electric

$84.67 /

-2.135 (-2.46%)

, GEHC

GE HealthCare

/

+

Oppenheimer analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
GE General Electric
$84.67 /

-2.135 (-2.46%)

GEHC GE HealthCare
/

+

GE General Electric
$84.67 /

-2.135 (-2.46%)

12/05/22 Deutsche Bank
General Electric price target raised to $94 from $89 at Deutsche Bank
11/22/22 Northland
Hyliion Holdings initiated with an Outperform at Northland
11/11/22 UBS
General Electric price target raised to $98 from $79 at UBS
10/27/22 Morgan Stanley
General Electric price target raised to $88 from $85 at Morgan Stanley
GEHC GE HealthCare
/

+

GE General Electric
$84.67 /

-2.135 (-2.46%)

GE General Electric
$84.67 /

-2.135 (-2.46%)

GE General Electric
$84.67 /

-2.135 (-2.46%)

GE General Electric
$84.67 /

-2.135 (-2.46%)

Hot Stocks
Acutus Medical receives CE Mark from EU MDR for AcQMap » 06:11
12/06/22
12/06
06:11
12/06/22
06:11
AFIB

Acutus Medical

/

+

Acutus Medical announced…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
AFIB Acutus Medical
/

+

AFIB Acutus Medical
/

+

06/24/22 BTIG
Acutus Medical price target lowered to $1.50 from $2.00 at BTIG
04/27/22 BTIG
Acutus Medical upgraded to Buy from Neutral at BTIG
02/24/22 JPMorgan
JPMorgan lays out potential takeover targets in medical technology
01/20/22 BTIG
BTIG cuts Acutus Medical to Neutral, says steeper expense reductions needed
AFIB Acutus Medical
/

+

Hot Stocks
Emergent BioSolutions: FDA accepts for review sNDA for Narcan Nasal Spray » 06:11
12/06/22
12/06
06:11
12/06/22
06:11
EBS

Emergent BioSolutions

$11.79 /

-0.21 (-1.75%)

Emergent BioSolutions…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
EBS Emergent BioSolutions
$11.79 /

-0.21 (-1.75%)

EBS Emergent BioSolutions
$11.79 /

-0.21 (-1.75%)

11/10/22 Benchmark
Benchmark downgrades Emergent on delay in smallpox vaccine fulfillment
11/10/22 Benchmark
Emergent BioSolutions downgraded to Hold from Buy at Benchmark
11/09/22 Chardan
Emergent BioSolutions price target lowered to $55 from $65 at Chardan
09/12/22 Cowen
Emergent BioSolutions price target lowered to $29 from $30 at Cowen
EBS Emergent BioSolutions
$11.79 /

-0.21 (-1.75%)

EBS Emergent BioSolutions
$11.79 /

-0.21 (-1.75%)

EBS Emergent BioSolutions
$11.79 /

-0.21 (-1.75%)

Hot Stocks
Emergent BioSolutions announces FDA acceptance of Narcan sNDA for review » 06:10
12/06/22
12/06
06:10
12/06/22
06:10
EBS

Emergent BioSolutions

$11.79 /

-0.21 (-1.75%)

Emergent BioSolutions…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
EBS Emergent BioSolutions
$11.79 /

-0.21 (-1.75%)

EBS Emergent BioSolutions
$11.79 /

-0.21 (-1.75%)

11/10/22 Benchmark
Benchmark downgrades Emergent on delay in smallpox vaccine fulfillment
11/10/22 Benchmark
Emergent BioSolutions downgraded to Hold from Buy at Benchmark
11/09/22 Chardan
Emergent BioSolutions price target lowered to $55 from $65 at Chardan
09/12/22 Cowen
Emergent BioSolutions price target lowered to $29 from $30 at Cowen
EBS Emergent BioSolutions
$11.79 /

-0.21 (-1.75%)

EBS Emergent BioSolutions
$11.79 /

-0.21 (-1.75%)

EBS Emergent BioSolutions
$11.79 /

-0.21 (-1.75%)

Hot Stocks
Matador raises quarterly dividend to 15c from 10c per share » 06:10
12/06/22
12/06
06:10
12/06/22
06:10
MTDR

Matador

$61.49 /

-4.355 (-6.61%)

Matador Resources…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
MTDR Matador
$61.49 /

-4.355 (-6.61%)

MTDR Matador
$61.49 /

-4.355 (-6.61%)

10/27/22 KeyBanc
Matador price target raised to $79 from $72 at KeyBanc
10/14/22 JPMorgan
Matador price target lowered to $67 from $71 at JPMorgan
09/26/22 Raymond James
Matador price target lowered to $60 from $70 at Raymond James
09/21/22 MKM Partners
MKM Partners assumed Matador with Buy and $68 price target yesterday
MTDR Matador
$61.49 /

-4.355 (-6.61%)

MTDR Matador
$61.49 /

-4.355 (-6.61%)

Downgrade
CapitaLand China Trust downgraded to Hold from Outperform at Daiwa » 06:09
12/06/22
12/06
06:09
12/06/22
06:09
CLDHF

CapitaLand China Trust

/

+

Daiwa analyst David Lum…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

Downgrade
Equitable Holdings cut to Sector Perform at RBC Capital on valuation » 06:09
12/06/22
12/06
06:09
12/06/22
06:09
EQH

Equitable Holdings

$31.04 /

-0.93 (-2.91%)

RBC Capital analyst Mark…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
EQH Equitable Holdings
$31.04 /

-0.93 (-2.91%)

EQH Equitable Holdings
$31.04 /

-0.93 (-2.91%)

05:15 Today RBC Capital
Equitable Holdings downgraded to Sector Perform from Outperform at RBC Capital
11/16/22 Citi
Equitable Holdings price target raised to $38 from $37 at Citi
10/19/22 Truist
Equitable Holdings price target lowered to $38 from $42 at Truist
10/10/22 Jefferies
Corebridge initiated with a Buy at Jefferies
EQH Equitable Holdings
$31.04 /

-0.93 (-2.91%)

Hot Stocks
Ocuphire Pharma submits NDA to FDA for Nyxol » 06:08
12/06/22
12/06
06:08
12/06/22
06:08
OCUP

Ocuphire Pharma

$3.22 /

-0.075 (-2.28%)

Ocuphire Pharma announced…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
OCUP Ocuphire Pharma
$3.22 /

-0.075 (-2.28%)

OCUP Ocuphire Pharma
$3.22 /

-0.075 (-2.28%)

11/09/22 Alliance Global Partners
Ocuphire partnership with FamyGen 'significant positive,' says Alliance Global
11/09/22 Canaccord
Ocuphire Pharma price target lowered to $22 from $29 at Canaccord
05/19/22 Alliance Global Partners
Alliance Global Partners says Ocuphire's Nyxol trial run 'remarkable'
OCUP Ocuphire Pharma
$3.22 /

-0.075 (-2.28%)

Upgrade
Weichai Power upgraded to Outperform from Hold at Daiwa » 06:08
12/06/22
12/06
06:08
12/06/22
06:08
WEICY

Weichai Power

$10.55 /

+0.02 (+0.19%)

Daiwa analyst Kelvin Lau…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
WEICY Weichai Power
$10.55 /

+0.02 (+0.19%)

05/31/22 JPMorgan
Weichai Power upgraded to Overweight from Underweight at JPMorgan
Downgrade
Oncorus downgraded to Neutral from Buy at H.C. Wainwright » 06:06
12/06/22
12/06
06:06
12/06/22
06:06
ONCR

Oncorus

/

+

H.C. Wainwright analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
ONCR Oncorus
/

+

ONCR Oncorus
/

+

11/30/22 Chardan
Oncorus downgraded to Neutral from Buy at Chardan
11/30/22 Piper Sandler
Piper downgrades Oncorus with plug pulled on lead program
11/30/22 Piper Sandler
Oncorus downgraded to Neutral from Overweight at Piper Sandler
11/02/22 Piper Sandler
Oncorus price target lowered to $6 from $12 at Piper Sandler
ONCR Oncorus
/

+

Hot Stocks
Celldex presents positive Phase 1b interim data from barzolvolimab in urticaria » 06:06
12/06/22
12/06
06:06
12/06/22
06:06
CLDX

Celldex

$36.70 /

-0.665 (-1.78%)

Celldex announced new…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
CLDX Celldex
$36.70 /

-0.665 (-1.78%)

CLDX Celldex
$36.70 /

-0.665 (-1.78%)

10/10/22 Jefferies
Third Harmonic Bio initiated with a Buy at Jefferies
07/01/22 H.C. Wainwright
Celldex price target raised to $73 from $60 at H.C. Wainwright
CLDX Celldex
$36.70 /

-0.665 (-1.78%)

CLDX Celldex
$36.70 /

-0.665 (-1.78%)

CLDX Celldex
$36.70 /

-0.665 (-1.78%)

Hot Stocks
NRG Energy to acquire Vivint Smart Home for $12 per share, or $2.8B cash » 06:05
12/06/22
12/06
06:05
12/06/22
06:05
NRG

NRG Energy

$40.84 /

-0.415 (-1.01%)

, VVNT

Vivint Smart Home

$8.98 /

-0.44 (-4.67%)

NRG Energy (NRG) and…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
NRG NRG Energy
$40.84 /

-0.415 (-1.01%)

VVNT Vivint Smart Home
$8.98 /

-0.44 (-4.67%)

NRG NRG Energy
$40.84 /

-0.415 (-1.01%)

06/07/22 BofA
NRG Energy downgraded to Underperform from Neutral at BofA
04/21/22 BofA
NRG Energy downgraded to Neutral from Buy at BofA
01/05/22 UBS
NRG Energy downgraded to Neutral from Buy at UBS
01/05/22 UBS
NRG Energy downgraded to Neutral from Buy at UBS
VVNT Vivint Smart Home
$8.98 /

-0.44 (-4.67%)

11/03/22 Maxim
Alarm.com price target lowered to $80 from $90 at Maxim
10/17/22 Morgan Stanley
Vivint Smart Home price target lowered to $7.30 from $7.50 at Morgan Stanley
06/28/22 Evercore ISI
Vivint Smart Home price target lowered to $6 from $8 at Evercore ISI
06/13/22 JPMorgan
Vivint Smart Home price target lowered to $10 from $11 at JPMorgan
NRG NRG Energy
$40.84 /

-0.415 (-1.01%)

VVNT Vivint Smart Home
$8.98 /

-0.44 (-4.67%)

NRG NRG Energy
$40.84 /

-0.415 (-1.01%)

Initiation
Ipsen reinstated with an Equal Weight at Barclays » 06:04
12/06/22
12/06
06:04
12/06/22
06:04
IPSEY

Ipsen

$28.06 /

+ (+0.00%)

Barclays analyst Emily…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
IPSEY Ipsen
$28.06 /

+ (+0.00%)

IPSEY Ipsen
$28.06 /

+ (+0.00%)

12/02/22 Jefferies
Ipsen resumed with a Buy at Jefferies
11/21/22 JPMorgan
Ipsen price target raised to C$115 from C$91 at JPMorgan
11/03/22 UBS
Ipsen price target raised to EUR 107 from EUR 102 at UBS
11/01/22 Societe Generale
Ipsen price target raised to EUR 142 from EUR 139 at Societe Generale
IPSEY Ipsen
$28.06 /

+ (+0.00%)

Initiation
Richter Gedeon initiated with an Outperform at RBC Capital » 06:03
12/06/22
12/06
06:03
12/06/22
06:03
RGEDF

Richter Gedeon

$19.80 /

+ (+0.00%)

RBC Capital analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

Hot Stocks
NRG Energy to acquire Vivint Smart Home for $12 per share, or $2.8B cash  06:02
12/06/22
12/06
06:02
12/06/22
06:02
NRG

NRG Energy

$40.84 /

-0.415 (-1.01%)

, VVNT

Vivint Smart Home

$8.98 /

-0.44 (-4.67%)

 
ShowHide Related Items >><<
NRG NRG Energy
$40.84 /

-0.415 (-1.01%)

VVNT Vivint Smart Home
$8.98 /

-0.44 (-4.67%)

NRG NRG Energy
$40.84 /

-0.415 (-1.01%)

06/07/22 BofA
NRG Energy downgraded to Underperform from Neutral at BofA
04/21/22 BofA
NRG Energy downgraded to Neutral from Buy at BofA
01/05/22 UBS
NRG Energy downgraded to Neutral from Buy at UBS
01/05/22 UBS
NRG Energy downgraded to Neutral from Buy at UBS
VVNT Vivint Smart Home
$8.98 /

-0.44 (-4.67%)

11/03/22 Maxim
Alarm.com price target lowered to $80 from $90 at Maxim
10/17/22 Morgan Stanley
Vivint Smart Home price target lowered to $7.30 from $7.50 at Morgan Stanley
06/28/22 Evercore ISI
Vivint Smart Home price target lowered to $6 from $8 at Evercore ISI
06/13/22 JPMorgan
Vivint Smart Home price target lowered to $10 from $11 at JPMorgan
NRG NRG Energy
$40.84 /

-0.415 (-1.01%)

VVNT Vivint Smart Home
$8.98 /

-0.44 (-4.67%)

NRG NRG Energy
$40.84 /

-0.415 (-1.01%)

Earnings
Conn's reports Q3 non-GAAP EPS (78c), consensus (83c) » 06:02
12/06/22
12/06
06:02
12/06/22
06:02
CONN

Conn's

$8.61 /

-1.21 (-12.32%)

Reports Q3 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
CONN Conn's
$8.61 /

-1.21 (-12.32%)

CONN Conn's
$8.61 /

-1.21 (-12.32%)

04/11/22 Stephens
Conn's assumed with an Equal Weight at Stephens
CONN Conn's
$8.61 /

-1.21 (-12.32%)

CONN Conn's
$8.61 /

-1.21 (-12.32%)

Initiation
Meituan initiated with an Overweight at Atlantic Equities » 05:59
12/06/22
12/06
05:59
12/06/22
05:59
MPNGF

Meituan

$21.62 /

-0.88 (-3.91%)

Atlantic Equities analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
MPNGF Meituan
$21.62 /

-0.88 (-3.91%)

11/29/22 Bernstein
Meituan price target lowered to HK$170 from HK$210 at Bernstein
10/28/22 Barclays
Meituan price target lowered to $16 from $21 at Barclays
09/02/22 Barclays
Meituan price target raised to $21 from $18 at Barclays
06/03/22 Macquarie
Meituan upgraded to Outperform from Neutral at Macquarie
MPNGF Meituan
$21.62 /

-0.88 (-3.91%)

Initiation
Veeva initiated with a Market Perform at Cowen » 05:58
12/06/22
12/06
05:58
12/06/22
05:58
VEEV

Veeva

$167.12 /

-7.75 (-4.43%)

Cowen analyst Charles…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
VEEV Veeva
$167.12 /

-7.75 (-4.43%)

VEEV Veeva
$167.12 /

-7.75 (-4.43%)

12/05/22 KeyBanc
Veeva price target lowered to $210 from $220 at KeyBanc
12/05/22 Citi
Salesforce price target lowered to $164 from $170 at Citi
12/02/22 Morgan Stanley
Veeva assumed with an Equal Weight at Morgan Stanley
12/02/22 Needham
Veeva price target raised to $220 from $205 at Needham
VEEV Veeva
$167.12 /

-7.75 (-4.43%)

VEEV Veeva
$167.12 /

-7.75 (-4.43%)

VEEV Veeva
$167.12 /

-7.75 (-4.43%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.